The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2026

Filed:

Jun. 25, 2025
Applicant:

Kyorin Pharmaceutical Co., Ltd., Tokyo, JP;

Inventors:

Mariangela Urbano, San Diego, CA (US);

Eun-Kyong Kim, San Diego, CA (US);

Chixu Chen, San Diego, CA (US);

Damoder R. Motati, San Diego, CA (US);

Romelo Gibe, La Jolla, CA (US);

Shyama Herath, San Diego, CA (US);

Qiang Li, Carlsbad, CA (US);

Naresh Gunaganti, San Diego, CA (US);

Xiuwen Zhu, San Diego, CA (US);

Mohammad B. Khaled, San Diego, CA (US);

Jonathan S. Rosenblum, San Diego, CA (US);

Hugh Rosen, Rancho Santa Fe, CA (US);

Sean Riley, San Diego, CA (US);

Emme C.K. Lin Fishburn, San Diego, CA (US);

Ryosuke Namie, Nogi-machi, JP;

Akihiko Kojima, Nogi-machi, JP;

Yoshikazu Asahina, Nogi-machi, JP;

Yosuke Nishigaya, Shiraoka, JP;

Muneki Nagao, Shiraoka, JP;

Akihiko Kasamatsu, Saitama, JP;

Takekazu Kondo, Nogi-machi, JP;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/429 (2006.01); A61K 31/437 (2006.01); A61K 31/444 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/5365 (2006.01); A61K 31/537 (2006.01); A61K 31/553 (2006.01); A61P 17/00 (2006.01); C07B 59/00 (2006.01); C07D 487/04 (2006.01); C07D 513/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 519/00 (2013.01); A61K 31/429 (2013.01); A61K 31/437 (2013.01); A61K 31/444 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/5365 (2013.01); A61K 31/537 (2013.01); A61K 31/553 (2013.01); A61P 17/00 (2018.01); C07B 59/002 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 513/04 (2013.01);
Abstract

The present disclosure relates to compounds represented by structural formula (I*): or a pharmaceutically acceptable salt thereof. Further disclosed are pharmaceutical compositions comprising the compounds and methods of treating an MRGPRX2-mediated disease or disorder using the compounds.


Find Patent Forward Citations

Quick Actions:

Urbano, Mariangela. (2026). Mrgprx2 antagonists, pharmaceutical composition including mrgprx2 antagonist, and method of treating mrgprx2-mediated disease or disorder (U.S. Patent No. 12799140). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12799140

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…